SCHEMBL7309905

SCHEMBL7309905

O=C(OCc1cccnc1)Oc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
MEN1 O00255 2/20 0.57
HTT P42858 2/20 0.57
GFER P55789 1/20 0.57
HSD17B10 Q99714 1/20 0.57
LMNA P02545 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
CYP19A1 P11511 2/20 0.56
CYP17A1 P05093 1/20 0.56
NAMPT P43490 2/20 0.50
NAPRT Q6XQN6 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
TSHR P16473 1/20 0.48
EPHX1 P07099 1/20 0.48
HSD11B1 P28845 1/20 0.47
CYP3A4 P08684 1/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
HDAC1 Q13547 1/20 0.45
CHRNA7 P36544 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6213582 0.91 KMT2A (0.64) KMT2AMEN1HTTGFERHSD17B10
SCHEMBL4245622 0.85 KMT2A (0.58) KMT2AMEN1HTTLMNATDP1
SCHEMBL697595 0.84 KMT2A (0.60) KMT2AMEN1HTTGFERHSD17B10
SCHEMBL9663709 0.83 CYP19A1 (0.61) KMT2AMEN1HTTGFERHSD17B10
SCHEMBL1126283 0.83 MAPT (0.60) KMT2AMEN1HTTCYP19A1CYP17A1
Carbamic Acid SCHEMBL9362680 0.82 KMT2A (0.57) KMT2AMEN1HTTGFERHSD17B10
SCHEMBL4245629 0.80 KMT2A (0.61) KMT2AMEN1HTTLMNATDP1
SCHEMBL14351314 0.80 KMT2A (0.53) KMT2AMEN1HTTLMNATDP1
SCHEMBL14351315 0.80 KMT2A (0.53) KMT2AMEN1HTTHSD17B10LMNA
SCHEMBL29556883 0.80 KMT2A (0.53) KMT2AMEN1HTTHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0488301-A1 New benzopyran compounds with pharmacological activity J. URIACH & CIA. S.A. (ES) 1992-06-03 EP disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed